Search results
The BBC World Service has undertaken an investigation of unproven treatments for retinitis pigmentosa (RP) and has produced a documentary film, called Blind Faith, which is available on BBC iPlayer.
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Financial support for young people attending conference
People living with sight loss in Scotland are able to benefit from free ferry travel for their companion when travelling with Caledonian MacBrayne (CalMac) Ferries with the NEC+1 card. The ferries operate across Scotland’s islands.
The latest podcast from Retina UK.
Ocugen’s gene therapy candidate, OCU410ST, is an experimental treatment designed to slow vision loss in Stargardt disease, an inherited retinal disease (IRD) with no approved therapies currently.
Volunteers are highly valued members of the Retina UK team and essential to our ability to achieve our vision of a world where all those affected by inherited retinal conditions are able to live a fulfilling life.
Inside this edition, register now for our AI webinar on 7 December with Dr Nikolas Pontikos.
The cover of this edition celebrates the success of our amazing London Marathon team. Together they have raised more than £43,000.
Are you affected by inherited sight loss? We are here to help.
